LOS ANGELES, Jan. 2, 2025 /PRNewswire/ — Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQ: HUMA). IF YOU SUFFERED A LOSS ON YOUR HUMACYTE…